Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nobuo Funao
Phase III, Randomised, Double-Blind, Multicentre Study to Evaluate the Efficacy and Safety of Vonoprazan Compared With Lansoprazole in Asian Patients With Erosive Oesophagitis
Gut
Gastroenterology
Related publications
Randomised Clinical Trial: Vonoprazan Versus Lansoprazole for the Initial Relief of Heartburn in Patients With Erosive Oesophagitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
OP0253 a Phase Iii Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept or Placebo on Standard of Care in Patients With Active Class Iii or Iv Lupus Nephritis
Efficacy and Safety of Velmanase Alfa in the Treatment of Patients With Alpha-Mannosidosis: Results From the Core and Extension Phase Analysis of a Phase III Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
Journal of Inherited Metabolic Disease
Genetics
A Phase 2, Randomized, Double-Blind, Multicenter Trial to Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared With Fluconazole in Patients With Uncomplicated Esophageal Candidiasis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Efficacy and Safety of Subcutaneous Tabalumab, a Monoclonal Antibody to B-Cell Activating Factor, in Patients With Systemic Lupus Erythematosus: Results From ILLUMINATE-2, a 52-Week, Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
A Phase III Randomized Study to Evaluate the Efficacy and Safety of CT-P13 Compared With Reference Infliximab in Patients With Active Rheumatoid Arthritis: 54-Week Results From the PLANETRA Study
Arthritis Research & Therapy
Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
Drugs and Aging
Gerontology
Geriatrics
Pharmacology
A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
Efficacy of Antibiotic Treatment in Patients With Chronic Low Back Pain and Modic Changes (The AIM Study): Double Blind, Randomised, Placebo Controlled, Multicentre Trial
British Medical Journal
Medicine
